AGCO Power Unveils Next-Generation Sustainable Powertrain Innovations at Agritechnica 2025
30.10.2025 09:00:00 EET | Business Wire | Press release
At Agritechnica 2025 in Hanover, AGCO Power will unveil a bold vision for the future of agricultural and forestry machinery powertrain solutions—combining cutting-edge diesel technology with pioneering low-carbon innovations designed to meet the evolving needs of farmers worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030745855/en/
Juha Heikkilä (left), Manager Electrification, holds NMC battery cells used in the prototype battery, while Kari Aaltonen, Director Engineering, stands beside the concept unit. The battery, designed by AGCO Power, contains a total of 1400 cells and offers 150 kWh of capacity.
Highlights include the newest and next‑generation CORE diesel engine family—the 8‑liter, 252 kW CORE80 powering the new 5th‑generation of the Fendt 800 Vario—alongside the AGCO Power CO₂ Calculator concept and a 150 kWh Future Battery Concept developed in‑house by AGCO Power, and cost-effective remanufactured engines that extend machine lifespans while reducing environmental impact.
AGCO Power’s innovations support farmers as they transition from fossil diesel to sustainable, low‑carbon options—and address today’s realities as well, from emissions reduction to continuous improvements in total cost of ownership.
“We believe the future of agricultural energy lies in a smart combination of fuels and technologies. There is no single solution—rather, a wider spectrum of power sources is needed. That’s why we are committed to exploring a wide range of innovations, investing significantly in R&D and our Clean Energy Lab, and promoting collaboration across the industry,” says Juha Tervala, the Vice President and Managing Director of AGCO Power.
AGCO Power designs and manufactures engines and power sources for AGCO’s world-leading tractor brands—Fendt, Massey Ferguson, and Valtra—as well as for other off-road machinery and work equipment.
AGCO Power Future Battery Concept
Making its world premiere at Agritechnica, AGCO Power’s Future Battery Concept is the company’s latest product development project. The concept battery is based on NMC cell chemistry and offers 150 kWh of capacity. The battery is designed by AGCO Power.
AGCO Power is closely tracking advances in battery cell technology and evaluating multiple chemistries, including solid‑state batteries. According to Director Engineering Kari Aaltonen, battery technology currently appears promising for agricultural applications.
“Today, the best way for a farmer to achieve emission‑free operation is with a battery‑electric driveline. Most regular farm work can, in the future, be completed with a tractor equipped with this battery. The challenge will be very long working days, but high‑power DC charging will enable operators to resume work in around 40 minutes,” says Kari Aaltonen.
Electric powertrains also offer clear advantages for work machines: lower operating costs than conventional powertrains and an almost service‑free setup. Aaltonen estimates that powertrains based on the concept battery could reach production in 5–7 years.
New CORE80 powering the new Fendt 800 Vario Gen5
At Agritechnica, the newest member of AGCO’s modern CORE diesel engine family, the CORE80, powers the new Fendt 800 Vario Gen5. As the biggest and smartest of the family, the 8‑liter CORE80 delivers even more torque (1680 Nm) and power (252 kW).
AGCO Power CORE engines have already proven top‑tier efficiency according to measurements by the independent DLG Test Centre. In the PowerMix Test 2.0 of the German Agricultural Society (DLG, Deutsche Landwirtschafts‑Gesellschaft), tractors are assessed for fuel and AdBlue consumption under typical workloads on a rolling test bench to determine overall energy efficiency.
“The combination of power and low fuel consumption makes it possible for farmers to work economically while protecting the environment,” says Roland Schmidt, Vice President, Fendt Marketing.
The smaller CORE50 and CORE75 engines will also be on display at Agritechnica. All CORE engines are manufactured at AGCO Power’s Linnavuori site in Finland. The new, low‑emission and energy‑efficient CORE engines are already in use in leading Fendt models: the 5‑liter, four‑cylinder AGCO Power CORE50 powers the Fendt 500 Vario Gen4 and Fendt 600 Vario series, while the 7.5‑liter CORE75 powers the Fendt 700 Vario Gen7 series.
AGCO Power CO₂ Calculator concept with Valtra
In collaboration with Valtra, AGCO Power will present its CO₂ Calculator concept at Agritechnica. The solution detects the type of fuel used and calculates the operational carbon footprint of agricultural machinery. It combines an engine-mounted fuel sensor with a cloud-based software solution that calculates accurate CO₂ emissions in real time. The visualized and stored data enables farmers to present verified figures to customers and supply chain partners.
“Reliable data on the operational carbon footprint is a major competitive advantage for farmers. It enables more informed decisions and allows them to track, visualize, and verify their environmental impact,” says Jarno Ratia, Director of Product Management of AGCO Power.
Agricultural traders also recognize the value of the solution. Bianca Lind, Managing Director of VERAVIS GmbH, a wholly owned subsidiary of Agravis Raiffeisen AG states:
“VERAVIS GmbH is committed to supporting farmers in meeting the requirements of the EU Green Deal while ensuring sustainable and profitable crop production. By integrating the AGCO Power CO₂ Calculator, we enhance the accuracy of our site- and crop-specific Product Carbon Footprint calculations. Validated, site-specific fuel usage data strengthens the credibility of sustainability reporting and simplifies documentation for all stakeholders—especially the farmer.”
Remanufactured engines: a cost‑effective solution for older machines
AGCO will also demonstrate at Agritechnica how the company supports farmers by remanufacturing used diesel engines to new condition. For the end user, a factory‑remanufactured engine offers fast availability as a replacement for a worn unit and significantly lower investment costs compared to a brand‑new engine.
At AGCO Power’s Linnavuori factory in Finland, a renewed remanufacturing production line has just been completed, increasing capacity from over 1,000 engines to 2,500 engines per year. This expansion supports the company’s long‑term strategy and Farmer First approach.
“Remanufacturing can lower total cost of ownership and reduce the carbon footprint versus a new machine—and, crucially, it can minimize downtime when engine problems occur. Remanufactured engines extend machine lifespans and enable up to 80% of an engine’s mass to be reused, including all cast‑iron components,” says Jussi Rinne, Director, Quality and Aftermarket.
About AGCO
AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers value to farmers and OEM customers through its differentiated brand portfolio including leading brands Fendt®, Massey Ferguson®, PTx and Valtra®. AGCO's full line of equipment, smart farming solutions and services helps farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $11.7 billion in 2024. For more information, visit www.agcocorp.com.
About AGCO Power
AGCO Power is one of the world’s leading developers and manufacturers of engines for off-road machines. We produce engines for well-known tractor brands such as Fendt, Valtra, and Massey Ferguson. In addition to these, AGCO Power engines are used in other off-road machines, including forestry equipment. Production facilities are located in Finland, China, Brazil, and Argentina. The Linnavuori plant has been operating for over 80 years and is a subsidiary of AGCO Corporation. www.agcopower.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251030745855/en/
Contacts
Media Contacts
Vilja Pylsy, vilja.pylsy@agcocorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom